| Literature DB >> 22206437 |
Tao Guo1, Xin F Liu, Xiang B Ding, Fei F Yang, Yong W Nie, Yu J An, Hong Guo.
Abstract
ω-3 polyunsaturated fatty acids have been shown to play an important role in health. Enriched with ω-3 polyunsaturated fatty acids modulate expression of a number of genes with such broad functions as cell proliferation, growth and apoptosis and cell signaling and transduction, these effects, seem to regulate coronary artery disease, hypertension, atherosclerosis, psychiatric disorders and various cancer. In this context, fat-1 transgenic cattle was designed to convert ω-6 to ω-3 fatty acids could form an ideal model to study the effect of ω-3 fatty acids on the above functions. This study focuses on the total genomic difference of gene expression between fat-1 transgenic cattle and wild-type using cDNA microarrays, several genes were found to be overexpressed or suppressed in transgenic cattle relative to wild-type, these discrepancy genes related with lipid metabolism, immunity, inflammation nervous development and fertility.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22206437 PMCID: PMC3267699 DOI: 10.1186/1476-511X-10-244
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Gene expression that either upregulated or downregulated in the whole genome of fat-1 transgenic cattle (p-value < 0.05 and fc ≥ 1)
| Genbank Accession | Gene name | Fold change |
|---|---|---|
| carnitine palmitoyltransferase 1 | 1.635675 | |
| cytochrome P450, family 2, subfamily E, polypeptide 1 | 3.129168 | |
| cytochrome P450, family 2, subfamily S, polypeptide 1 | 1.085825 | |
| cytochrome P450, family 3, subfamily A, polypeptide 4 | 1.0726473 | |
| cytochrome P450, family 4, subfamily F, polypeptide 3 | 1.021228 | |
| ATPase, H+ transporting, lysosomal 31 kDa, V1 subunit E1 | 1.0310035 | |
| ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 | 1.0874296 | |
| peroxisome proliferator activated receptor | 1.1880234 | |
| low density lipoprotein receptor-related protein 5 | -1.1805074 | |
| low density lipoprotein receptor-related protein 4 | -1.5911577 | |
| Indoleamine 2, 3-dioxygenase | 2.0460057 | |
| granulocyte-macrophage colony-stimulating-factor receptor α | 2.167638 | |
| interleukin-2 receptor α | -2.3078954 | |
| interleukin-1, beta | -2.8775382 | |
| interferon-γ | -2.1359362 | |
| nterleukin-6 | -1.8120259 | |
| interleukin-10 receptor α | -1.107485 | |
| CD4 molecule | -1.19058 | |
| WC1 | -6.185475 | |
| lymphocyte-activation gene 3 | -2.201507 | |
| similar to Zeta-chain associated protein kinase 70 kDa | -2.379626 | |
| acetylserotonin O-methyltransferase | -2.1411839 | |
| prostaglandin E receptor 4 | -1.1957332 | |
| prostaglandin E synthase 2 | -1.0895984 | |
| mature T-cell proliferation 1 | -1.0484107 | |
| T-cell receptor delta chain | -2.3310187 | |
| T-cell acute lymphocytic leukemia 2 | -1.1402003 | |
| lymphocyte-specific protein 1 | -1.2811403 | |
| immunoglobulin-like domain containing receptor 2 | -1.6142586 | |
| lymphocyte cytosolic protein 2 | -1.2404228 | |
| lymphocyte cytosolic protein 1 | -1.0534877 | |
| cell adhesion molecule 1 | 10.783385 | |
| acireductone dioxygenase 1 | 2.893599 | |
| suppression of tumorigenicity 7 like | 1.1566072 | |
| serpin peptidase inhibitor | 7.2662635 | |
| RAS-like, family 10, member A | 2.4159741 | |
| serine/threonine kinase 38 like | 1.0883793 | |
| NLR family, pyrin domain containing 13 | 2.8275476 | |
| DnaJ (Hsp40) homolog, subfamily B, member 6 | 1.0343608 | |
| nuclear receptor subfamily 2, group F, member 1 | 1.1831405 | |
| chondroitin sulfate proteoglycan 4 | -2.4661286 | |
| TNF receptor-associated factor 7 | -1.182513 | |
| L1 cell adhesion molecule | -2.0497224 | |
| adenomatosis polyposis coli 2 | -2.1012108 | |
| laminin, alpha 4 | -2.7227702 | |
| matrix metallopeptidase 3 | -2.013966 | |
| matrix metallopeptidase 15 | -1.0679191 | |
| matrix metallopeptidase 1 | -1.0266808 | |
| matrix metallopeptidase 16 | -1.1511999 | |
| matrix metallopeptidase 20 | -1.0834453 | |
| nitric oxide synthase interacting protein | -1.027486 | |
| nitric oxide synthase 2 | -1.1507416 | |
| prostaglandin E receptor 4 | -1.1957332 | |
| prostaglandin E synthase | -1.0576057 | |
| prostaglandin E synthase 2 | -1.0895984 | |
| claudin 10 | -1.221211 | |
| β-catenin | -2.1087096 | |
| NF-kB | -1.7619956 | |
| NF-kB activating protein-like | -1.2362162 | |
| Huntingtin interacting protein-1 | 2.2835305 | |
| transforming growth factor, beta receptor II | -1.1494738 | |
| transforming growth factor beta 1 induced transcript 1 | -1.560125 | |
| transforming growth factor, beta receptor III | -1.0382366 | |
| tumor protein p53 binding protein 1 | -1.1203252 | |
| tumor protein p53 | -1.1353312 | |
| gamma-glutamyltransferase 7 | -2.7013438 | |
| protocadherin gamma subfamily A, 6 | 4.1054792 | |
| protocadherin gamma subfamily A, 8 | 3.6014705 | |
| protocadherin gamma subfamily B, 4 | 1.5915743 | |
| protocadherin gamma subfamily A, 9 | 3.789133 | |
| potassium channel, subfamily K, member 10 | 1.2212783 | |
| Olfactory receptor 13H1 | 4.0936475 | |
| SEPTIN5 | 2.3829544 | |
| nucleoredoxin-like 2 | 6.2915673 | |
| semaphorin 5B | -3.1176894 | |
| Calmegin | 2.228811 | |
| SRY (sex determining region Y)-box 8 | 1.8772229 | |
| EF-hand calcium binding domain 6 | -2.55162 |